Thus, BPs are analogues of calcium pyrophosphate and also inhibit the activity of APL by binding to Zn++ and to Mg ++(both needed for ALP activity).5, 30 For this reason, these drugs would be particularly contraindicated in hypophosphatasia, because they would worsen bone mineralization. Here, FASLG is linked to hypophosphatasia.